ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca.

Six years after his Alzheimer’s diagnosis, 90-year-old Zelik Bocknek (Zel) refuses to slow down — and he believes his active lifestyle is key to keeping his symptoms at bay.

The Company provided the above adjusted supplemental financial performance measures, which are considered "non-GAAP" financial measures under applicable SEC rules and regulations. These financial ...

After the former president's 2024 election victory, many people question how much of this Republican-led plan he will ...

Announced positive interim data for DURAVYU 2.7mg in DME demonstrating meaningful, early and sustained visual acuity gains, strong anatomical ...

An urgent health warning has been issued to to anyone drinking apple cider this autumn ... Not only will the drink hydrate ...

Cash runway is not expected to get Intellia to meaningful data readouts for their Phase III trials. See why NTLA stock is a ...

FemiPro is a bladder health supplement specifically formulated to support female wellness. It works by targeting harmf ...

Soil conservation has always been the foundation of the Natural Resources Conservation Service, which for nearly 60 years was ...

Book onto an open day and visit us to find out why our students voted us University of the Year 2024 at the Whatuni Student Choice Awards. Make Sheffield the start of something special. When you study ...

Aside from using bleaching or body whitening creams to enhance children’s complexion, findings showed that many desperate ...